Below is a cut from an announcement of 10th November 2015 referring to the diagnostic accuracy achieved by the ResAppDx algorithm at that time. By now its spectrogram cough signals will have been refined further to higher resolution by inclusion of another six years of collected audio datasets.
I think it is clear MB that the clinical trials are simply evaluating the diagnostic capabilities of the participating clinicians, and not those of ResAppDx. Unfortunately it is difficult to prove that you are the gold standard when you have nothing accurate to compare to, but the publication just released adds some justification to that argument.
RAP Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held